A

Abingworth Portfolio holdings

AUM $307M
This Quarter Return
+50.1%
1 Year Return
+93.6%
3 Year Return
+207.29%
5 Year Return
+452.78%
10 Year Return
AUM
$358M
AUM Growth
+$358M
Cap. Flow
+$134M
Cap. Flow %
37.51%
Top 10 Hldgs %
97.5%
Holding
17
New
1
Increased
1
Reduced
1
Closed
1

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
PCVX icon
1
Vaxcyte
PCVX
$4B
$132M 36.77% +4,168,718 New +$132M
PSNL icon
2
Personalis
PSNL
$434M
$70.6M 19.75% 5,449,294
PHAT icon
3
Phathom Pharmaceuticals
PHAT
$864M
$39.4M 11.01% 1,203,135
CRSP icon
4
CRISPR Therapeutics
CRSP
$4.71B
$38.1M 10.64% 519,198
SLNO icon
5
Soleno Therapeutics
SLNO
$3.6B
$22.8M 6.37% 10,302,602 +3,333,330 +48% +$7.37M
XCUR icon
6
Exicure
XCUR
$35.4M
$17M 4.74% 6,977,000
SRRA
7
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$10.5M 2.95% 876,541
SIEN
8
DELISTED
Sientra, Inc.
SIEN
$9.23M 2.58% 2,390,843
PRTK
9
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$5.42M 1.52% 1,041,131
VRNA
10
Verona Pharma
VRNA
$9.16B
$4.22M 1.18% 901,943
TARA icon
11
Protara Therapeutics
TARA
$120M
$3M 0.84% 53,612 -60,307 -53% -$3.38M
MTEM
12
DELISTED
Molecular Templates, Inc.
MTEM
$2.76M 0.77% 200,000
SYRE icon
13
Spyre Therapeutics
SYRE
$996M
$2.22M 0.62% 240,500
OBSV
14
DELISTED
ObsEva SA Ordinary Shares
OBSV
$517K 0.14% 87,999
CBAY
15
DELISTED
Cymabay Therapeutics
CBAY
$456K 0.13% 131,036
OCGN icon
16
Ocugen
OCGN
$319M
$2K ﹤0.01% 7,111
CHMA
17
DELISTED
Chiasma, Inc. Common Stock
CHMA
-370,671 Closed -$1.35M